Ivermectin, an antiparasitic medication used to treat infections like river blindness and intestinal roundworms, is generally well tolerated at prescribed doses. Its most common side effects are mild and digestive in nature: nausea, diarrhea, abdominal pain, and dizziness. However, the drug carries some serious risks depending on the type of infection being treated, the dose taken, and individual factors like genetics and pregnancy status.
Common Side Effects
At standard prescribed doses, ivermectin’s side effects tend to be short-lived and manageable. The most frequently reported include nausea, vomiting, diarrhea, stomach pain, dizziness, headache, and mild skin rash. These typically resolve on their own without treatment. Less commonly, people experience blurred vision, joint or muscle pain, swollen lymph nodes, and fatigue.
The severity and type of side effects can vary depending on which parasite is being treated. That distinction matters because many of ivermectin’s more dramatic reactions aren’t caused by the drug itself, but by the body’s immune response to dying parasites.
Reactions From Dying Parasites
When ivermectin kills large numbers of parasites at once, the immune system can mount an intense inflammatory response to the debris. In patients treated for river blindness (onchocerciasis), this is called a Mazzotti reaction. It can occur within seven days of treatment and is characterized by fever, intense itching, hives, swollen and tender lymph nodes, rapid heartbeat, low blood pressure, joint pain, swelling, and abdominal pain. The itching is typically worst in areas of the body where the parasites are most concentrated.
Some of these symptoms, like the hives and swelling, are straightforward allergic responses. But the fever, rapid heartbeat, and drops in blood pressure look more like the body is fighting a blood infection, which reflects how aggressively the immune system can react to massive parasite die-off. In rare cases, the Mazzotti reaction can be life-threatening.
Loa Loa Encephalopathy
One of ivermectin’s most dangerous scenarios involves patients who are co-infected with a parasitic worm called Loa loa, common in parts of Central and West Africa. When the parasite load in the blood is very high, ivermectin can trigger a severe brain inflammation called encephalopathy. The risk rises sharply when parasite levels exceed 30,000 organisms per milliliter of blood, a threshold associated with a 1,000-fold increase in the chance of a serious adverse event. In mass treatment campaigns, health workers now use a portable diagnostic tool to screen patients and withhold treatment from those with dangerously high parasite levels.
Neurological Effects and How the Brain Stays Protected
Ivermectin works by paralyzing parasites through their nervous systems. In mammals, the brain is normally shielded from this effect by a protein pump called P-glycoprotein, which sits at the blood-brain barrier and actively pushes ivermectin back out before it can reach brain tissue. This pump is the main reason the drug has a wide safety margin in humans at normal doses.
Problems arise when this protective pump isn’t working properly. Certain genetic variations reduce the pump’s effectiveness, allowing ivermectin to cross into the brain. Some medications can also interfere with the pump or slow the body’s breakdown of ivermectin. Because ivermectin is processed primarily by a liver enzyme called CYP3A4, drugs that block this enzyme (including some HIV medications and antifungals) can raise ivermectin levels in the blood. If you’re taking other medications, your prescriber should check for potential interactions before starting ivermectin.
Overdose and Toxicity
At doses well above the prescribed range, ivermectin toxicity follows a recognizable pattern. It starts with gastrointestinal symptoms: nausea, vomiting, and diarrhea. As toxicity worsens, neurological symptoms appear, including confusion, hallucinations, blurred vision, tremors, loss of coordination and balance, decreased alertness, seizures, and in severe cases, coma. Cardiovascular effects like low blood pressure and rapid heart rate can also occur.
During the COVID-19 pandemic, the CDC documented a surge in ivermectin-related poisonings after people began self-medicating with veterinary formulations. Animal ivermectin products are formulated at concentrations designed for horses or cattle weighing hundreds of pounds, and they contain inactive ingredients that have never been tested for human safety. The FDA received multiple reports of patients requiring hospitalization after taking these products. The FDA has not authorized or approved ivermectin for preventing or treating COVID-19.
Liver Effects
Liver injury from ivermectin is rare but documented. The first published case of severe ivermectin-induced hepatitis involved a young woman treated for a Loa loa infection who developed significant liver inflammation about a month after a single dose. A liver biopsy showed inflammatory damage and tissue death consistent with drug-induced liver disease. While this remains uncommon, it’s a recognized possibility, particularly in patients with high parasite burdens where the combined stress of parasite die-off and drug metabolism may strain liver function.
Pregnancy and Breastfeeding
Ivermectin’s safety during pregnancy remains uncertain. The FDA previously classified it as a pregnancy category C drug, meaning animal studies showed harmful effects on the fetus, but no adequate human studies exist. Early animal toxicity studies found problems at doses 20 to 600 times higher than what humans receive, though those studies were later questioned because the mouse strain used had a genetic deficiency in the same protective pump (P-glycoprotein) that normally keeps ivermectin out of sensitive tissues.
Despite that limitation in the animal data, no research has been sufficient to confirm ivermectin is safe for pregnant women. In mass treatment campaigns for parasitic diseases across Africa and other endemic regions, pregnant women are routinely excluded from ivermectin distribution as a precaution, based on visible pregnancy or self-reporting. No pregnancy testing is required, but treatment is withheld out of caution given the knowledge gaps.
Veterinary Products Carry Extra Risks
A critical distinction exists between ivermectin formulated for humans and products sold for animals. Veterinary ivermectin comes in paste, pour-on, and injectable forms with concentrations calibrated for large animals. These formulations contain different inactive ingredients that haven’t been evaluated for human use, making both the dose and the delivery vehicle unpredictable in people. The FDA has emphasized that animal and human formulations are not interchangeable and that using veterinary products on yourself poses serious, potentially life-threatening risks.